362 related articles for article (PubMed ID: 33347810)
1. Cost-effectiveness of point-of-care testing with task-shifting for HIV care in South Africa: a modelling study.
Sharma M; Mudimu E; Simeon K; Bershteyn A; Dorward J; Violette LR; Akullian A; Abdool Karim SS; Celum C; Garrett N; Drain PK
Lancet HIV; 2021 Apr; 8(4):e216-e224. PubMed ID: 33347810
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of point-of-care viral load monitoring of antiretroviral therapy in resource-limited settings: mathematical modelling study.
Estill J; Egger M; Blaser N; Vizcaya LS; Garone D; Wood R; Campbell J; Hallett TB; Keiser O;
AIDS; 2013 Jun; 27(9):1483-92. PubMed ID: 23462219
[TBL] [Abstract][Full Text] [Related]
3. Impact and Cost-Effectiveness of Point-Of-Care CD4 Testing on the HIV Epidemic in South Africa.
Heffernan A; Barber E; Thomas R; Fraser C; Pickles M; Cori A
PLoS One; 2016; 11(7):e0158303. PubMed ID: 27391129
[TBL] [Abstract][Full Text] [Related]
4. Protocol for a randomised controlled implementation trial of point-of-care viral load testing and task shifting: the Simplifying HIV TREAtment and Monitoring (STREAM) study.
Dorward J; Garrett N; Quame-Amaglo J; Samsunder N; Ngobese H; Ngomane N; Moodley P; Mlisana K; Schaafsma T; Donnell D; Barnabas R; Naidoo K; Abdool Karim S; Celum C; Drain PK
BMJ Open; 2017 Sep; 7(9):e017507. PubMed ID: 28963304
[TBL] [Abstract][Full Text] [Related]
5. Cost and cost-effectiveness of a universal HIV testing and treatment intervention in Zambia and South Africa: evidence and projections from the HPTN 071 (PopART) trial.
Thomas R; Probert WJM; Sauter R; Mwenge L; Singh S; Kanema S; Vanqa N; Harper A; Burger R; Cori A; Pickles M; Bell-Mandla N; Yang B; Bwalya J; Phiri M; Shanaube K; Floyd S; Donnell D; Bock P; Ayles H; Fidler S; Hayes RJ; Fraser C; Hauck K;
Lancet Glob Health; 2021 May; 9(5):e668-e680. PubMed ID: 33721566
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of community-based strategies to strengthen the continuum of HIV care in rural South Africa: a health economic modelling analysis.
Smith JA; Sharma M; Levin C; Baeten JM; van Rooyen H; Celum C; Hallett TB; Barnabas RV
Lancet HIV; 2015 Apr; 2(4):e159-68. PubMed ID: 25844394
[TBL] [Abstract][Full Text] [Related]
7. Comparative cost analysis of point-of-care versus laboratory-based testing to initiate and monitor HIV treatment in South Africa.
Simeon K; Sharma M; Dorward J; Naidoo J; Dlamini N; Moodley P; Samsunder N; Barnabas RV; Garrett N; Drain PK
PLoS One; 2019; 14(10):e0223669. PubMed ID: 31618220
[TBL] [Abstract][Full Text] [Related]
8. Point-of-care HIV viral load testing combined with task shifting to improve treatment outcomes (STREAM): findings from an open-label, non-inferiority, randomised controlled trial.
Drain PK; Dorward J; Violette LR; Quame-Amaglo J; Thomas KK; Samsunder N; Ngobese H; Mlisana K; Moodley P; Donnell D; Barnabas RV; Naidoo K; Abdool Karim SS; Celum C; Garrett N
Lancet HIV; 2020 Apr; 7(4):e229-e237. PubMed ID: 32105625
[TBL] [Abstract][Full Text] [Related]
9. Acceptability of point-of-care viral load testing to facilitate differentiated care: a qualitative assessment of people living with HIV and nurses in South Africa.
Msimango L; Gibbs A; Shozi H; Ngobese H; Humphries H; Drain PK; Garrett N; Dorward J
BMC Health Serv Res; 2020 Nov; 20(1):1081. PubMed ID: 33239012
[TBL] [Abstract][Full Text] [Related]
10. Home testing and counselling to reduce HIV incidence in a generalised epidemic setting: a mathematical modelling analysis.
Ying R; Sharma M; Celum C; Baeten JM; van Rooyen H; Hughes JP; Garnett G; Barnabas RV
Lancet HIV; 2016 Jun; 3(6):e275-82. PubMed ID: 27240790
[TBL] [Abstract][Full Text] [Related]
11. Cost-effectiveness of point-of-care versus centralised, laboratory-based nucleic acid testing for diagnosis of HIV in infants: a systematic review of modelling studies.
le Roux SM; Odayar J; Sutcliffe CG; Salvatore PP; de Broucker G; Dowdy D; McCann NC; Frank SC; Ciaranello AL; Myer L; Vojnov L
Lancet HIV; 2023 May; 10(5):e320-e331. PubMed ID: 37149292
[TBL] [Abstract][Full Text] [Related]
12. The clinical and economic impact of point-of-care CD4 testing in mozambique and other resource-limited settings: a cost-effectiveness analysis.
Hyle EP; Jani IV; Lehe J; Su AE; Wood R; Quevedo J; Losina E; Bassett IV; Pei PP; Paltiel AD; Resch S; Freedberg KA; Peter T; Walensky RP
PLoS Med; 2014 Sep; 11(9):e1001725. PubMed ID: 25225800
[TBL] [Abstract][Full Text] [Related]
13. Simplifying TREAtment and Monitoring for HIV (STREAM HIV): protocol for a randomised controlled trial of point-of-care urine tenofovir and viral load testing to improve HIV outcomes.
Bardon AR; Dorward J; Sookrajh Y; Sayed F; Quame-Amaglo J; Pillay C; Feutz E; Ngobese H; Simoni JM; Sharma M; Cressey TR; Gandhi M; Lessells R; Moodley P; Naicker N; Naidoo K; Thomas K; Celum C; Abdool Karim S; Garrett N; Drain PK
BMJ Open; 2021 Oct; 11(10):e050116. PubMed ID: 34610939
[TBL] [Abstract][Full Text] [Related]
14. The value of point-of-care CD4+ and laboratory viral load in tailoring antiretroviral therapy monitoring strategies to resource limitations.
Hyle EP; Jani IV; Rosettie KL; Wood R; Osher B; Resch S; Pei PP; Maggiore P; Freedberg KA; Peter T; Parker RA; Walensky RP
AIDS; 2017 Sep; 31(15):2135-2145. PubMed ID: 28906279
[TBL] [Abstract][Full Text] [Related]
15. The cost-effectiveness of monitoring strategies for antiretroviral therapy of HIV infected patients in resource-limited settings: software tool.
Estill J; Salazar-Vizcaya L; Blaser N; Egger M; Keiser O
PLoS One; 2015; 10(3):e0119299. PubMed ID: 25793531
[TBL] [Abstract][Full Text] [Related]
16. Monitoring of HIV viral load, CD4 cell count, and clinical assessment versus clinical monitoring alone for antiretroviral therapy in low-resource settings (Stratall ANRS 12110/ESTHER): a cost-effectiveness analysis.
Boyer S; March L; Kouanfack C; Laborde-Balen G; Marino P; Aghokeng AF; Mpoudi-Ngole E; Koulla-Shiro S; Delaporte E; Carrieri MP; Spire B; Laurent C; Moatti JP;
Lancet Infect Dis; 2013 Jul; 13(7):577-86. PubMed ID: 23602084
[TBL] [Abstract][Full Text] [Related]
17. Laboratory Monitoring of Antiretroviral Therapy for HIV Infection: Cost-Effectiveness and Budget Impact of Current and Novel Strategies.
Ouattara EN; Robine M; Eholié SP; MacLean RL; Moh R; Losina E; Gabillard D; Paltiel AD; Danel C; Walensky RP; Anglaret X; Freedberg KA
Clin Infect Dis; 2016 Jun; 62(11):1454-1462. PubMed ID: 26936666
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care CD4 testing to inform selection of antiretroviral medications in south african antenatal clinics: a cost-effectiveness analysis.
Ciaranello AL; Myer L; Kelly K; Christensen S; Daskilewicz K; Doherty K; Bekker LG; Hou T; Wood R; Francke JA; Wools-Kaloustian K; Freedberg KA; Walensky RP
PLoS One; 2015; 10(3):e0117751. PubMed ID: 25756498
[TBL] [Abstract][Full Text] [Related]
19. Cost Effectiveness of Potential ART Adherence Monitoring Interventions in Sub-Saharan Africa.
Phillips AN; Cambiano V; Nakagawa F; Bansi-Matharu L; Sow PS; Ehrenkranz P; Ford D; Mugurungi O; Apollo T; Murungu J; Bangsberg DR; Revill P
PLoS One; 2016; 11(12):e0167654. PubMed ID: 27977702
[TBL] [Abstract][Full Text] [Related]
20. Initiating antiretroviral therapy for HIV at a patient's first clinic visit: a cost-effectiveness analysis of the rapid initiation of treatment randomized controlled trial.
Long LC; Maskew M; Brennan AT; Mongwenyana C; Nyoni C; Malete G; Sanne I; Fox MP; Rosen S
AIDS; 2017 Jul; 31(11):1611-1619. PubMed ID: 28463879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
